| 序号 |
批准日期 |
商品名 |
活性成分 |
公司全称 |
注册审批号 |
规格 |
剂型/给药途径 |
参比药物 |
参比标准 |
市场状态 |
| 1 |
2026-05-29 |
EPINEPHRINE |
EPINEPHRINE |
HIKMA |
|
1MG/ML (1MG/ML) |
SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS |
No |
No |
RX |
| 2 |
2026-05-29 |
CAVHANZA |
NILOTINIB |
FLEX PHARMA |
|
60MG |
TABLET, ORALLY DISINTEGRATING;ORAL |
Yes |
No |
RX |
| 3 |
2026-05-29 |
CAVHANZA |
NILOTINIB |
FLEX PHARMA |
|
80MG |
TABLET, ORALLY DISINTEGRATING;ORAL |
Yes |
Yes |
RX |
| 4 |
2026-05-29 |
OXCARBAZEPINE |
OXCARBAZEPINE |
MSN |
|
300MG/5ML |
SUSPENSION;ORAL |
No |
No |
RX |
| 5 |
2026-05-29 |
ZAYNICH |
CEFEPIME HYDROCHLORIDE; ZIDEBACTAM |
WOCKHARDT BIO AG |
|
EQ 2GM BASE/VIAL;1GM/VIAL |
POWDER;INTRAVENOUS |
Yes |
Yes |
RX |
| 6 |
2026-05-29 |
XOCOVA |
ENSITRELVIR |
SHIONOGI |
|
125MG |
TABLET;ORAL |
Yes |
Yes |
RX |
| 7 |
2026-05-28 |
DEFLAZACORT |
DEFLAZACORT |
CARNEGIE |
|
22.75MG/ML |
SUSPENSION;ORAL |
No |
No |
RX |
| 8 |
2026-05-28 |
SODIUM SULFATE, MAGNESIUM SULFATE AND POTASSIUM CHLORIDE |
MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM SULFATE |
LUPIN |
|
0.225GM;0.188GM;1.479GM |
TABLET;ORAL |
No |
No |
RX |
| 9 |
2026-05-27 |
CARBOPROST TROMETHAMINE |
CARBOPROST TROMETHAMINE |
SOMERSET THERAPS LLC |
|
EQ 0.25MG BASE/ML |
INJECTABLE;INJECTION |
No |
No |
RX |
| 10 |
2026-05-27 |
LINAGLIPTIN |
LINAGLIPTIN |
TEVA PHARMS USA |
|
5MG |
TABLET;ORAL |
No |
No |
RX |